{
    "organizations": [],
    "uuid": "86c3c54e78ec2c7d1dcca736ca76593c751a88e4",
    "author": "",
    "url": "https://in.reuters.com/video/2018/04/09/novartis-to-buy-avexis-in-87bn-gene-ther?videoId=416242967",
    "ord_in_thread": 0,
    "title": "Novartis to buy AveXis in $8.7bn gene-therapy deal",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Novartis to buy AveXis in $8.7bn gene-therapy deal Monday, April 09, 2018 - 01:28 \nSwiss drugmaker Novartis is moving further into gene therapy by buying AveXis for $8.7 billion, adding a rare-disease treatment that could reap billions in sales. Kate King reports.   \nSwiss drugmaker Novartis is moving further into gene therapy by buying AveXis for $8.7 billion, adding a rare-disease treatment that could reap billions in sales. Kate King reports.  //reut.rs/2qic6b6",
    "published": "2018-04-09T15:45:00.000+03:00",
    "crawled": "2018-04-09T16:25:13.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "novartis",
        "buy",
        "avexis",
        "deal",
        "monday",
        "april",
        "swiss",
        "drugmaker",
        "novartis",
        "moving",
        "gene",
        "therapy",
        "buying",
        "avexis",
        "billion",
        "adding",
        "treatment",
        "could",
        "reap",
        "billion",
        "sale",
        "kate",
        "king",
        "report",
        "swiss",
        "drugmaker",
        "novartis",
        "moving",
        "gene",
        "therapy",
        "buying",
        "avexis",
        "billion",
        "adding",
        "treatment",
        "could",
        "reap",
        "billion",
        "sale",
        "kate",
        "king",
        "report"
    ]
}